Buyers Are Betting On A Cancer Therapy With These Stocks

“Some of the smaller companies developing immunotherapy drugs could be acquired by the pharmaceutical giants, analysts said.
“CAR-T cell therapy is a form of immunotherapy, a rapidly developing cancer treatment that uses patients’ own immune cells to attack tumors.
In contrast, the typical, less efficient method of treating cancer uses combinations of surgery, chemotherapy and radiation to kill cancer cells.
“In addition to the potential for medical breakthrough, most analysts who spoke with CNBC also noted that cancer drugs are not subject to increased political pressure to lower prices.
The overall cancer death rate in the U.S. fell 13 percent from 2004 to 2013, according to the SEER Cancer Statistics Review from Sept. 2016.

Read more on: